Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Artelo Biosciences, Inc. (ARTL) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.37M |
|
-- |
|
-- |
|
$2.38M |
|
$-2.38M |
|
$0.01M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.37M |
|
$-2.38M |
|
$-2.38M |
|
3.28M |
|
3.28M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$1.38M |
|
-- |
|
$2.13M |
|
$3.52M |
|
$2.80M |
|
-- |
|
$0.06M |
|
$2.86M |
|
$0.65M |
|
$-1.39M |
|
$0.65M |
|
3.28M |
|
| Cash Flow Statement Financials | |
$-1.60M |
|
-- |
|
-- |
|
$2.34M |
|
$0.75M |
|
$-1.59M |
|
$0.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.49 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-363.80% |
|
171.02% |
|
-67.48% |
|
-363.80% |
|
$0.20 |
|
$-0.49 |
|
$-0.49 |
|